No, yeast infections are not listed as a recognised adverse effect of Wegovy by the MHRA, and there is no established pharmacological mechanism linking semaglutide to Candida overgrowth
They made the entire process easy
Information about ongoing UK trials can be found via the NIHR Be Part of Research website (bepartofresearch.nihr.ac.uk) or the ClinicalTrials.gov database
Bottom line: MeAgain is the better next step if your GLP-1 journey feels scattered and you want everything in one place
#NDASA #KnowYourNumbers To view or add a comment, sign in It is the worst kept secret in workplace testing, screening programs using old technology or employers just following the same old policy are not producing the results they should
Monitoring : Regular monitoring of blood glucose levels, hemoglobin A1c labs, weight loss, and any potential side effects during the transition period are critical